FDA Panel Backs mRNA Flu Vaccine for Older Adults
An advisory panel to the Food and Drug Administration (FDA) has unanimously recommended the approval of the first messenger RNA (mRNA) influenza vaccine, specifically targeting older adults. The vote, which took place on June 18, 2026, marks a significant step toward potentially offering a new method for protecting a vulnerable population against seasonal flu. The […]